Pharmacology Lecture: Adverse Drug Reactions & Interactions

Administrative & Course Logistics

  • In-class activity submission link
    • Always located in the course Module area.
  • ATI (Assessment Technologies Institute) access
    • Instructor verified that (almost) everyone now has access.
    • Students confirmed ATI content clarified lecture topics.
  • Key upcoming deadlines
    • Introduction to Pharmacology module test due 11-th at 11:59 p.m.
    • All current ATI module exams & submissions due by Friday 23:59 (except Safe-Medication module—see below).
    • Safe Medication Administration module exam must be finished by Sunday 23:59 so its content can be used for Monday review.
  • Exam schedule
    • First pharmacology exam covers material from Day 1 (yesterday), Day 2 (today) & Day 3 (Monday).
    • Exam date: next Tuesday (exact time TBA); multiple-choice format, possible “select-all-that-apply,” no True/False.
  • Optional study hall
    • Monday, 1 – 2 p.m. in classroom; will include a pharmacology “Bingo” review game.
  • Additional ATI resources
    • In ATI dashboard → My ATI → Review Modules 2023 RN → eBooks
    • Accessible PDFs for Fundamentals, Leadership, Pharmacology, etc.
  • File-upload tips
    • LMS allows multiple attachments (e.g., front & back of worksheets).
    • Organizational advice: keep personal calendar, track deadlines, time-management = professionalism.

Warm-Up & Review: Kahoot Game

  • Purpose: 7-question, non-graded review of prior lecture.
  • 1st, 2nd, 3rd place received small prizes (suckers, miscellaneous gifts).
  • Representative questions & correct responses
    • “Where are most drugs metabolized?” → Liver.
    • “Which route is parenteral?” (choose all) → IV, IM, sub-Q, etc.
    • Reinforced concepts of excretion (kidneys) & drug classifications.
  • Class observations
    • No laptop notes taken during game; instructor teased “boring ones.”
    • Students enthusiastic; affirmed comprehension gaps for later focus.

Expected Pharmacological Action vs Therapeutic Use

  • Expected pharmacological action
    • The direct mechanism of action a drug exerts in the body (cellular/biochemical effect).
    • Physicians select drugs based on this action.
    • Example: Antibiotics disrupt bacterial cell wall replication → kill or inhibit microbes.
  • Therapeutic use
    • The clinical reason the drug is prescribed; desired patient outcome.
    • Drugs often have multiple therapeutic uses:
    • Ibuprofen: antipyretic and anti-inflammatory/analgesic.
    • Diphenhydramine (Benadryl): allergy relief and motion-sickness prophylaxis.

Side Effects vs Adverse Drug Reactions (ADR)

  • Side effect (secondary effect)
    • Predictable, often dose-dependent, sometimes tolerable or self-limiting.
    • Eg: Benadryl → drowsiness & dry mouth; GI upset from many PO meds.
  • Adverse drug reaction (ADR)
    • Unintended, undesired, potentially harmful outcomes when drug given correctly.
    • Range: mild rash → severe anaphylaxis.

Primary vs Secondary Adverse Actions

  • Primary (overdose) action
    • Excess drug concentration → exaggerated pharmacology.
    • Examples:
    • \text{Warfarin} overdose → uncontrolled bleeding.
    • Excess antihypertensive → hypotension, syncope.
  • Secondary adverse action
    • Diverse effects beyond desired action, unrelated to dose.
    • Example: Antihistamines ↓ secretions & depress CNS → sedation.

Common ADRs by Body System

  • Central Nervous System (CNS): agitation, confusion, psychosis, seizures, coma, respiratory depression.
  • Gastrointestinal (GI): N/V, diarrhea/constipation, ulceration, GI bleed.
  • Hematologic: bone-marrow suppression, anemia, excessive clotting or bleeding.
  • Hepatotoxicity / Nephrotoxicity: impaired metabolism or excretion → drug accumulation.
  • Hypersensitivity / Allergy
    • IgE-mediated response to prior exposure; may progress to anaphylaxis
    • S/S: facial/lip edema, throat tightness, wheeze, \uparrow HR, \downarrow BP; can be fatal.
    • Example narrative: Instructor developed new amoxicillin rash → escalating reaction → required antihistamines & carries EpiPen.

Electrolyte, Glucose & Teratogenic Effects

  • Potassium imbalance
    • Hypo/Hyper-kalemia → cardiac dysrhythmias.
  • Glucose dysregulation
    • Some drugs ↓ serum glucose; others ↑ by stimulating glycogenolysis.
  • Teratogenicity
    • Drugs crossing placenta causing fetal malformations, especially in 1st trimester.
    • Categorized A\rightarrow X (FDA).
    • A = controlled studies show no risk; X = contraindicated in pregnancy.

Tolerance, Cumulative Effect & Toxicity

  • Tolerance: ↓ physiologic response over time → need ↑ dose or change agent.
  • Cumulative effect
    • Impaired metabolism/excretion (e.g., renal/hepatic insufficiency) → incremental build-up.
    • Leads to toxicity if not monitored.
  • Toxicity
    • Harmful drug levels; may be irreversible.
    • Example: Vancomycin ototoxicity (cranial nerve VIII damage) → monitor peak & trough levels.

Precautions vs Contraindications

  • Precaution: Drug may be given but requires close monitoring.
    • Eg: Anticoagulant in pt with bleeding ulcer (benefit vs risk).
    • Populations: elderly, pregnant, breastfeeding, immunocompromised.
  • Contraindication: Absolute “do NOT give.”
    • Pediatric pt receiving adult dose; known penicillin allergy; known dangerous drug-drug interaction.

Drug–Drug Interactions (DDIs)

  • Possible outcomes: ↓ effect, ↑ effect, or new adverse effect.
  • Pharmacodynamic relationships
    • Antagonist: One drug blocks receptor/action of another (e.g., β-agonist bronchodilator + β-blocker).
    • Additive: Similar mechanisms → combined effect = sum (EtOH + sedative).
    • Synergistic: Different mechanisms → combined effect > sum (Pepcid + Prevacid for GERD; ASA + warfarin ↑ anticoagulation).
    • Agonist: Drug mimics endogenous ligand & stimulates receptor (serotonin agonists).

Food–Drug Interactions

  • Mechanisms
    1. ↑ Drug activity: Food enhances absorption or slows metabolism.
    • Iron + Vitamin C (orange juice) ↑ absorption.
    • Grapefruit inhibits CYP450 → ↑ serum levels of some Ca-channel blockers.
    1. ↓ Drug activity: Food binds drug or opposes its action.
    • Spinach (vit K) antagonizes warfarin.
    • High-fiber diet ↓ digoxin absorption.
    1. Toxic/Adverse combo
    • Acetaminophen + alcohol → hepatotoxicity.
    • MAO-Is + tyramine foods → hypertensive crisis.

Drug Therapy Across the Lifespan

  • Infants/Children
    • Immature liver/kidney; altered gastric pH; larger body-water %.
    • Doses based on age, weight, body-surface-area.
  • Elderly
    • ↓ renal/hepatic function, ↓ GI motility, ↑ gastric pH, ↓ cardiac output.
    • Prone to ADRs, dosing adjusted; vigilant lab monitoring.
  • Pregnancy
    • Placental transfer—many drugs cross barrier.
    • Category-based risk assessment (A-X).
    • Some drugs deferred until 2ᵈ/3ʳᵈ trimester.
  • Breastfeeding
    • Drugs can appear in milk; e.g., Benadryl decreases milk supply so discouraged postpartum.

Polypharmacy in Older Adults (Question 20 Context)

  • Multiple chronic illnesses → \ge 5 concurrent prescriptions common.
  • Risks
    • Confusion over schedules → missed or doubled doses.
    • ↑ probability of DDIs & cumulative toxicity.
    • Sensory/DEXTERITY issues (opening bottles, reading labels).
    • Cognitive decline affects adherence.
  • Nursing interventions: Medication reconciliation, pill organizers, simplified regimens, family/caregiver teaching.

Nursing Role: Client Education & Evaluation

  • Begin education at admission & continue.
  • Teach
    • Drug name(s) – generic & brand.
    • Purpose & mechanism.
    • Dose, route, timing (with/without food; diurnal variation).
    • Expected benefits & common side effects.
    • Serious ADRs: when to call provider/911.
    • Food, alcohol, OTC & herbal interactions.
  • Assess learner variables
    • Literacy, language, cognition, learning style (visual/audio/kinesthetic).
    • Provide written materials, pictograms, demonstrations.
  • Return demonstration / Teach-back to verify comprehension (e.g., insulin self-injection technique).
  • Document teaching & patient response.

Classroom Plans & Miscellany

  • Later collect handwritten answer to Question 20 (why elders on many meds at higher ADR risk).
  • Instructor reminder: “Tell me if I talk too fast.”
  • Microphone feedback resolved during lecture.
  • Encouragement: Use ATI + lecture slides; entire content fair game although test cannot cover everything.
  • Future interactive tools: Bingo review to make study session engaging.

Ethical & Practical Implications

  • Providers must weigh benefit vs risk (e.g., teratogenic drugs, anticoagulants with ulcers).
  • Nurses serve as last safety check; must understand pharmacology, monitor labs, advocate for dosage adjustments.
  • Patient autonomy: informed consent hinges on clear, culturally appropriate education.